Boston Scientific scored a 100 on the 2023 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. By complying with the HRC’s controversial demands, Boston Scientific increases the risk of dividing employees, alienating customers and harming shareholders. The company covers transgender-related medical costs for its employees and their children and provides specific sexual orientation and gender identity-based benefits. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Boston Scientific forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Boston Scientific is a corporate partner of the Human Rights Campaign (HRC) and pledged $3.5 million to BLM and related causes. The company supports the Equality Act and regularly uses its corporate reputation to advance gender ideology. Boston Scientific's CEO signed the CEO Action for Diversity & Inclusion pledge and the CEO Action for Racial Equity pledge. The company has donated to the Equality PAC and lobbied for the Equality Act. Boston Scientific opposed various state and local legislation intended to protect parental rights, girls’ sports, bathroom facilities, and gendered spaces. For these reasons, Boston Scientific receives a High Risk rating.